Hims & Hers Health (HIMS) Competitors $26.20 -0.16 (-0.61%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends HIMS vs. NTRA, FMS, GH, OPCH, SHC, VCYT, BTSG, LFST, SGRY, and CONShould you be buying Hims & Hers Health stock or one of its competitors? The main competitors of Hims & Hers Health include Natera (NTRA), Fresenius Medical Care (FMS), Guardant Health (GH), Option Care Health (OPCH), Sotera Health (SHC), Veracyte (VCYT), BrightSpring Health Services (BTSG), LifeStance Health Group (LFST), Surgery Partners (SGRY), and Concentra Group Holdings Parent (CON). These companies are all part of the "healthcare" industry. Hims & Hers Health vs. Natera Fresenius Medical Care Guardant Health Option Care Health Sotera Health Veracyte BrightSpring Health Services LifeStance Health Group Surgery Partners Concentra Group Holdings Parent Hims & Hers Health (NYSE:HIMS) and Natera (NASDAQ:NTRA) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, community ranking, risk, media sentiment, dividends, institutional ownership, analyst recommendations, profitability and earnings. Do analysts rate HIMS or NTRA? Hims & Hers Health presently has a consensus target price of $22.80, suggesting a potential downside of 12.98%. Natera has a consensus target price of $152.67, suggesting a potential downside of 5.69%. Given Natera's stronger consensus rating and higher probable upside, analysts plainly believe Natera is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hims & Hers Health 1 Sell rating(s) 8 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.41Natera 0 Sell rating(s) 0 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is HIMS or NTRA more profitable? Hims & Hers Health has a net margin of 8.19% compared to Natera's net margin of -14.01%. Hims & Hers Health's return on equity of 10.97% beat Natera's return on equity.Company Net Margins Return on Equity Return on Assets Hims & Hers Health8.19% 10.97% 8.29% Natera -14.01%-26.23%-14.27% Which has preferable earnings and valuation, HIMS or NTRA? Hims & Hers Health has higher earnings, but lower revenue than Natera. Natera is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHims & Hers Health$1.24B4.61-$23.55M$0.4459.55Natera$1.53B13.95-$434.80M-$1.76-91.98 Does the media favor HIMS or NTRA? In the previous week, Hims & Hers Health had 17 more articles in the media than Natera. MarketBeat recorded 29 mentions for Hims & Hers Health and 12 mentions for Natera. Natera's average media sentiment score of 1.10 beat Hims & Hers Health's score of 0.48 indicating that Natera is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 11 Very Positive mention(s) 5 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Natera 8 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, HIMS or NTRA? Hims & Hers Health has a beta of 1.25, suggesting that its share price is 25% more volatile than the S&P 500. Comparatively, Natera has a beta of 1.63, suggesting that its share price is 63% more volatile than the S&P 500. Do institutionals & insiders have more ownership in HIMS or NTRA? 63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 99.9% of Natera shares are held by institutional investors. 17.7% of Hims & Hers Health shares are held by insiders. Comparatively, 7.6% of Natera shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the MarketBeat Community believe in HIMS or NTRA? Natera received 440 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 68.82% of users gave Natera an outperform vote while only 38.61% of users gave Hims & Hers Health an outperform vote. CompanyUnderperformOutperformHims & Hers HealthOutperform Votes3938.61% Underperform Votes6261.39% NateraOutperform Votes47968.82% Underperform Votes21731.18% SummaryNatera beats Hims & Hers Health on 10 of the 18 factors compared between the two stocks. Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HIMS vs. The Competition Export to ExcelMetricHims & Hers HealthOffices & clinics of medical doctors IndustryMedical SectorNYSE ExchangeMarket Cap$5.72B$999.93M$5.10B$19.18BDividend YieldN/AN/A4.90%3.58%P/E Ratio59.5511.9191.0841.22Price / Sales4.611.311,113.5117.58Price / CashN/A42.9742.2621.28Price / Book16.277.884.785.32Net Income-$23.55M-$52.07M$119.77M$989.67M7 Day Performance-12.72%-5.17%-1.87%-3.45%1 Month Performance9.46%0.17%11.46%-3.73%1 Year Performance204.83%-18.32%30.53%12.06% Hims & Hers Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HIMSHims & Hers Health3.3829 of 5 stars$26.20-0.6%$22.80-13.0%+214.3%$5.72B$1.24B59.551,046Analyst ForecastInsider TradeNews CoverageNTRANatera2.0549 of 5 stars$168.91+1.4%$152.67-9.6%+182.6%$22.30B$1.53B-94.633,293FMSFresenius Medical Care3.4832 of 5 stars$24.04+1.6%$24.30+1.1%+11.4%$14.11B$19.24B19.791,358News CoveragePositive NewsGHGuardant Health4.1067 of 5 stars$35.23+1.4%$40.60+15.2%+25.6%$4.35B$692.26M-8.201,779Positive NewsOPCHOption Care Health4.861 of 5 stars$23.60+0.5%$30.14+27.7%-29.9%$4.02B$4.78B19.747,802Positive NewsSHCSotera Health3.5846 of 5 stars$13.14-0.1%$16.08+22.4%-20.0%$3.72B$1.05B52.603,000Positive NewsVCYTVeracyte4.0132 of 5 stars$43.61+0.9%$41.13-5.7%+49.0%$3.38B$361.05M-288.13790Positive NewsBTSGBrightSpring Health Services2.3113 of 5 stars$18.95+2.1%$18.50-2.4%N/A$3.30B$10.59B-71.3835,000Analyst ForecastPositive NewsLFSTLifeStance Health Group1.7047 of 5 stars$7.80+8.8%$8.70+11.5%-0.3%$2.98B$1.21B-29.509,325Positive NewsGap UpSGRYSurgery Partners3.2475 of 5 stars$21.91+7.6%$36.56+66.8%-33.8%$2.78B$2.74B-42.4213,500CONConcentra Group Holdings ParentN/A$21.63+5.5%$28.50+31.8%N/A$2.75B$1.88B0.0011,000Gap Up Related Companies and Tools Related Companies NTRA Competitors FMS Competitors GH Competitors OPCH Competitors SHC Competitors VCYT Competitors BTSG Competitors LFST Competitors SGRY Competitors CON Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:HIMS) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HIMS Stock Alerts